Duke's Business School Forms Health Sector Advisory Council
November 21, 2002
DURHAM, N.C. -- Duke University's Fuqua School of Business has formed its first Health Sector Advisory Council (HSAC), Health Sector Management Faculty Director Kevin Schulman announced Friday.
Formed to provide faculty, students and staff with an outside perspective on health care, HSAC will keep student education and faculty research relevant and problem-centered as the school pursues its mission of expanding the boundaries of theory-based knowledge, Schulman said.
The council, consisting of senior executives from various health care companies as well as faculty and students from several areas of Duke, will review new trends, emerging technologies and research-grounded insights into the fast-changing health care environment.
"We're delighted to have the involvement of senior health care executives in the HSM program. Our program, our students and our faculty all benefit by having their participation," said Schulman. "The council will, in turn, serve as a portal into all the health care resources Duke has to offer in business, medicine, law and public policy along with other health care-related departments."
The chair of HSAC, George Abercrombie, said the HSAC council will not benefit Duke and Fuqua, but will give senior executives the opportunity to interact with those students who will be major decision-makers in the marketplace in future years.
"It will be significant to have contact with Fuqua students and faculty, as well as other Duke departmental faculty from medicine, the Clinical Research Institute, economics, law and public policy," said Abercrombie, president and CEO of Hoffman-LaRoche. "I think we'll also gain some fresh insights into the emerging health care marketplace."
HSAC membership is by invitation of Fuqua Dean Douglas Breeden and Schulman. It will meet twice a year. Members are: Jack Bovender, chairman and CEO, HCA; Bill Ashton, vice president of corporate accounts, Amgen; Mike Doodson, senior vice president, Merck; Andrea Galzer, senior vice president, CIGNA; Tom Grein, treasurer, Eli Lilly; Bill Heiden, president, Praecis; Stan Hull, senior vice president, US Pharmaceuticals, GlaxoSmithKline; Vince Kerr, director, health care management, Ford Motor Co.; Ray Lipicky, visiting scientist, Woods Hole Marine Biological Laboratory and former director of Cardio-Renal Drug Products, FDA; Jim Mackey, senior vice president, Schering Plough; Beth O'Brien, senior vice president, network operations, CIGNA Healthcare; U.S. Rep. David Price, D-N.C.; Ray Russo, director, therapeutic marketing, Schering Plough; Mark Salyer, senior vice president, sales & marketing, Altana Pharma; Nicky Spaulding, president, cardiac surgery, Guidant Corp.; Sid Stolz, senior vice president, account services, AdvancePCS; Joe Swedish (alumni representative), Centura Health System; Tim Tyson, president, global manufacturing and supply, GlaxoSmithKline; Hans Vemer, president & CEO, Organon Technika; and Bobba Venkatadri, executive vice president, operations, Diosynth RTP, Akzo Nobel subsidiary of Organon Technika.
Members of the HSAC from Duke include Robert Califf, director, Duke Clinical Research Institute and associate vice chancellor of Clinical Research; Brian Freeman, student liaison, class of 2004, Health Sector
Management Program, Fuqua; Henry Grabowski, professor, economics; Will Mitchell, professor, Fuqua; Jeffrey L. Moe, director, health sector emerging issues and development, Fuqua; Stephen Morales, student liaison, class of 2003, Health Sector Management Program, Fuqua; Schulman; and Frank Sloan, J. Alex McMahon professor of healthcare policy and management.
For information about the council, contact Moe, (919) 660-2936, or Schulman, (919) 668-8101.